Search - tctmd.com

Displaying 241 - 260 of 561

Sort: Relevancy | Date

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

Presentation

Evolution in Practice Patterns and Long-term Outcome of Coronary Revascularization from the BMS to DES Eras in Japan

Presenter: H. Shiomi

March 19, 2014

News Daily News

Transcatheter Pulmonary Valve Implantation Feasible in Smaller Children

March 05, 2014

News Daily News

After PCI, Major Bleeding Predicts Higher Mortality Mainly in Anemic Patients

February 26, 2014

News Daily News

Moderate/Severe Calcification in ACS Patients Linked to Worse Post-PCI Outcomes

Yael L. Maxwell

February 20, 2014

News Daily News

ACS患者的中度/重度钙化会导致PCI后结果恶化

Yael L. Maxwell

February 20, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

February 12, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

Bioresorbable Scaffold Performs Well in Select STEMI Patients

January 22, 2014

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

News Daily News

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

January 09, 2014

News Daily News

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

January 09, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

January 01, 2014

Presentation

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

Presenter: Alfredo E. Rodriguez

December 30, 2013

News Daily News

荟萃分析：CABG在冠状动脉多支病变治疗的长期发病率、死亡率方面优于PCI

Yael L. Maxwell

December 30, 2013

News Daily News

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

December 30, 2013

Advertisement

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Evolution in Practice Patterns and Long-term Outcome of Coronary Revascularization from the BMS to DES Eras in Japan

Transcatheter Pulmonary Valve Implantation Feasible in Smaller Children

After PCI, Major Bleeding Predicts Higher Mortality Mainly in Anemic Patients

Moderate/Severe Calcification in ACS Patients Linked to Worse Post-PCI Outcomes

ACS患者的中度/重度钙化会导致PCI后结果恶化

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

DUTCH PEERS Publicado: Los Stents liberadores de Zotarolimus y Everolimus de 3ª Generación son Equivalentes

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

Bioresorbable Scaffold Performs Well in Select STEMI Patients

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

EES Reduce Revascularization vs. BMS Regardless of Kidney Disease Severity

Comparados con los SMD, los SLE Reducen la Revascularización con Independencia de la Severidad de la Enfermedad Renal

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta Análisis: Comparados con los SMD, los SLF de Última Generación son Seguros y Eficaces contra los cuadros de STEMI

Comparison of Cost-Effectiveness of Oral Rapamycin Plus BMS vs. First-Generation DES

荟萃分析：CABG在冠状动脉多支病变治疗的长期发病率、死亡率方面优于PCI

Un Análisis Revela que, comparados con los SMD, los SLF Reducen la RVD pero No la Mortalidad en Pacientes Muy Ancianos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content